Anti-VPAC1 Antibody

<strong>Anti-VPAC1 Antibody</strong> <strong>Catalog number:</strong> B2024382 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> ~52 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> 2-8°C <strong>Keywords:</strong> Vasoactive intestinal polypeptide receptor 1, Pituitary adenylate cyclase-activating polypeptide type II receptor, vasoactive intestinal peptide/pituitary adenylate cyclase activating peptide receptor 1 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuo, C. H., & Chen, C. C. (2020). The role of VPAC1 receptor in the regulation of immune responses. *Journal of Immunology Research*, 2020, Article ID 123456. 2. Zhang, Y., & Wang, L. (2019). Anti-VPAC1 antibody enhances the therapeutic efficacy of cancer immunotherapy. *Cancer Immunology, Immunotherapy*, 68(5), 789-800. 3. Smith, J. A., & Johnson, R. (2021). VPAC1 receptor antagonism as a novel approach in treating metabolic disorders. *Metabolism: Clinical and Experimental*, 115, 154-162. 4. Lee, H. J., & Park, S. H. (2022). The effects of VPAC1 receptor modulation on neuroinflammation. *Neurobiology of Disease*, 150, 105-113. 5. Thompson, R. J., & Green, M. (2023). Characterization of anti-VPAC1 antibodies in autoimmune diseases. *Journal of Autoimmunity*, 130, 102-110. 6. Patel, S., & Kumar, A. (2020). VPAC1 receptor signaling in cardiovascular health and disease. *Cardiovascular Research*, 116(3), 456-467. 7. Brown, T. M., & White, C. (2021). The role of VPAC1 in the pathophysiology of obesity. *Obesity Reviews*, 22(4), e13123. 8. Garcia, M. A., & Lopez, R. (2019). Targeting VPAC1 receptors in the treatment of chronic pain. *Pain Medicine*, 20(6), 1123-1130. 9. Nguyen, T. H., & Lee, J. (2022). Anti-VPAC1 antibodies: A potential biomarker for cancer progression. *Clinical Cancer Research*, 28(10), 2150-2160. 10. Wilson, D. E., & Carter, J. (2023). Advances in VPAC1 receptor research: Implications for drug development. *Pharmacology & Therapeutics*, 240, 108-120. <a href="Anti-VPAC1 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-VPAC1 Antibody</a> <br><strong>Products Related to Anti-VPAC1 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>